Mandate

Vinge advised the buyers in connection with the acquisition of Mechanum

August 15, 2023 M&A

Vinge advised MGN Holding, consisting primarily of the founders and management of the company, in its acquisition of Mechanum from, among other sellers, Navigo Invest.

Mechanum is an authorised multi-brand workshop that performs service, repairs and warranty services passenger cars and transport vehicles. Mechanum had sales of approximately SEK 488 million during the 2022 financial year and has over 300 employees in total at its seven facilities in Gothenburg, Stockholm and Malmö.

 

Vinge's team primarily consisted of Carl Sander, Linus Adolfsson and Alexander Rüdén.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB.

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB. The final purchase price will be based on the outstanding loan volume in the portfolio as of closing date. As of March 2024, the outstanding loan volume in the portfolio amounted to approximately SEK 3.8 billion. The acquisition is subject to customary regulatory approvals.
April 22, 2024